Navignostics AG

Meet Stéphane Chevrier and Benjamin Ehret at this weeks Swiss & Austrian Pathology Meeting 2024 in Feldkirch! They will each be presenting exciting updates on clinical projects and how Navignostics AG will bring highly multiplex protein imaging into routine clinical application. https://lnkd.in/dy8EFkHu

Navignostics AG is growing! We are excited to welcome Cyrille Delley to the team. Cyrille has a Ph.D. in biophysics from ETH Zürich as well as vast postdoctoral experience in cancer biology, single-cell analysis and high-throughput assay development. His interdisciplinary background and spatial tissue analysis expertise make him a wonderful addition to the Navignostics team. Welcome Cyrille!

Proud to announce the most promising Swiss Biotech Startups and Scale-Ups of 2024, picked by a panel of 100 leading investors and industry experts. Read the full article: https://lnkd.in/dFD-CuCZ Discover the 15 Biotech Startups that impressed the TOP 100 Swiss Startup Award Jury in 2024: HAYA Therapeutics: Treating heart failure through innovative RNA-therapies. https://lnkd.in/dTqyuk_9 Araris Biotech AG: Building tomorrow's antibody-drug conjugates (ADCs). https://lnkd.in/dFRYX5g9 MUVON Therapeutics AG: Regain control with MUVON. https://lnkd.in/eaZrpZBU FimmCyte: First Disease Modifying Treatment for Endometriosis. https://lnkd.in/dYhuHXt4 Navignostics AG: Precision cancer treatment. https://lnkd.in/eH84t9q3 Noema Pharma: Beyond Symptom Control. https://lnkd.in/dAc5WdTR Recolony AG: Cancer immunotherapy inspired by symbiotic interactions. https://lnkd.in/egd_HKbV InkVivo Technologies AG: Best in class polymer platform for formulating drug delivery. https://lnkd.in/ey3ikTeF Perseo pharma AG: Next-Generation Enzyme Replacement Therapies. https://lnkd.in/dCwDGC_C GlycoEra AG: Glycobiology and protein degradation. https://lnkd.in/eMU3jRJa Limula: Cell and gene therapy made easy. https://lnkd.in/ecwJTvE4 Nagi Bioscience: “Organism-on-Chip” technology for drug/chemical screening. https://lnkd.in/ec4JkNG4 arcoscreen: We screen patients cells to improve drug discovery. https://lnkd.in/eepNRnZs Synendos Therapeutics AG: Therapies for neuropsychiatric disorders. https://lnkd.in/e4xdg6Av Tandem Therapeutics: Unlocking the matrix barrier in fibrotic diseases. https://lnkd.in/dacyKyqs About: The annual ranking of the TOP 100 Swiss Startups has become a benchmark in Switzerland’s startup ecosystem - and beyond. Every year, a panel of 100 leading investors and startup experts chooses the 100 most innovative and promising Swiss startups. Each jury member nominates 10 Swiss startups that are fewer than five years old and show the greatest commercial potential. They assign 10 points for the first place and one point for the tenth place. The companies with the most points make it into the TOP 100 Swiss Startup Ranking. #SwissStartups #BioTech #TOP100SSU

Swiss Innovation for Human Health!!! The #lifesciences in #Switzerland continue to thrive and grow as #startups spun-out from large pharma and new companies formed on the basis of #science and #innovation developed at highly rated ETH Zürich and EPFL advance along their chosen pathways and mature from research-focused organizations, to pre-clinical, development and finally commercial stages. With strong government support, most companies are located in clusters such as the BioValley Basel (headquarters of Novartis, Roche, Ciba, Clariant, Lonza and Roivant Sciences and branches of large pharmaceutical companies, such as Johnson & Johnson, Eli Lilly and Company, Pfizer and Sanofi), the Biopôle Lausanne (more than 100 companies and institutions, from start-ups to multinationals and 25 world-famous research groups) and the Bio-technopark Schlieren-zürich (over 50 companies and 30 academic institutions).  Looking at the logos listed the lobbies of the buildings there and getting sense of the energy and buzz in the hallways can be inspiring. Last week, as reported by Stefan Kyora and Startupticker.ch, Jordi Montserrat and Stefan Steiner from Venturelab hosted the 14th annual TOP 100 Startup Awards as assessed by a highly qualified jury; 16 #biotech and 12 #medtech companies were recognized. ** Samir Ounzain, Daniel Blessing and the team at HAYA Therapeutics – the winner of last year’s Top 100 Swiss Startup Award – was the top ranked biotech and took fifth place this year.  In addition, they announced collaboration with Eli Lilly that could bring the Lausanne-based start-up up to $1 billion. ** Matt Curran, Christophe Chautems, and Brad Nelson and the team at Nanoflex Robotics came in at 10th place and was the top scoring medtech company, recognnized for the endoluminal soft robotic systems that can be remotely manipulated within the bod. ** Jana Fischer, Andrea Jacobs, Stéphane Chevrier and the team at Navignostics AG was the top rated #diagnostics company, recognized for their approach to personalize treatment for each cancer patient’s disease using spatial single-cell proteomics. You can click on this link for the full list of the Top 100 Startupshttps://lnkd.in/e3pDm47u. The industry has strong suport from the Swiss Biotech Association which works to secure favorable framework conditions and facilitate access to talents, novel technologies and financial resources.  There are a growing number of funding sources; government sources such as Innosuisse and FONGIT , #venturecapital including #corporateventurecapital and #privateequity investors as well.  There are a number of highly competent #consultinggroups in Switzerland who partner with #entrepreneurs to help them address challenges they face. Additionally, there are a number of #incubatorprograms such as Venture Kick, MassChallenge Switzerland, BaseLaunch, Seedstars and many others (https://lnkd.in/eu5Te_uH). Innovation for human health is thriving in Switzerland!!!

Navignostics AG is growing! We are thrilled to welcome Bettina Herrmann to our team. With her >20 years experience as a quality professional and her practical, startup-oriented mindset, she is the perfect addition to our ambitious team. We are looking forward to jointly tackling the important upcoming milestones towards our first product release. Welcome Bettina!

Rank 34 this year!! Navignostics AG is climbing up in the TOP 100 Swiss Startups. #TOP100SSU

Do you know that cancer treatment is never a one-size-fits-all approach for patients? In this Sejelas Founder-CEO Interview series, we hear from Dr. Jana Fischer, the Co-Founder and CEO at Navignostics AG. The team specialises in spatial single-cell proteomic tumour analysis for better cancer treatment. Read the full article here: https://lnkd.in/gcbhATci #diagnostics #cancer #tumour #lifescience #sejelas #founderceo #interviewseries

Navignostics AG is happy to now be a member of Swiss Medtech. We are looking forward to the knowledge exchange with the community. https://lnkd.in/dDzQuzkA

It was a pleasure to show our offices and labs to the interested visitors at our new location in Horgen. Thank you Stiftung grow!

Over the past two years Navignostics AG has grown a lot as a company and as a team. Therefore, we are happy to launch our new website to give a face to the people behind our solutions. All photos on the website are of our actual team doing our daily work in our Horgen labs. Please check out our beautiful new website at https://lnkd.in/dj2ir6tp and get a picture of how we support our clinical and research partners. Huge thanks to Angina Herrmann and Ave-Lii Idavain at Maend as well as to Rachael Camp for creating this fantastic website with us. It came out exactly as we hoped.